APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalational Isoflurane

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalational Isoflurane Market Outlook and Growth Opportunities 2026

27 December 2025199 pages

Choose your research edition.

Industry ResearchInhalational Isoflurane Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalational Isoflurane Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Inhalational Isoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalational Isoflurane Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalational Isoflurane Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Inhalational Isoflurane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalational Isoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalational Isoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalational Isoflurane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalational Isoflurane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalational Isoflurane market include KALBE PHARMA, AbbVie, LAB UNKNOWN, Neon Laboratories, Piramal, PT Novell Pharmaceutical, Sedana Medical, Baxter and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalational Isoflurane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalational Isoflurane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalational Isoflurane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalational Isoflurane market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalational Isoflurane Segment by Company

KALBE PHARMA

AbbVie

LAB UNKNOWN

Neon Laboratories

Piramal

PT Novell Pharmaceutical

Sedana Medical

Baxter

Viatris

Lunan Beite

Inhalational Isoflurane Segment by Type

Brand Drug

Generic Drugs

Inhalational Isoflurane Segment by Application

Clinic

Hospital

Other

Inhalational Isoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhalational Isoflurane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalational Isoflurane market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalational Isoflurane significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalational Isoflurane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalational Isoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalational Isoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalational Isoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalational Isoflurane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalational Isoflurane industry.

Chapter 3: Detailed analysis of Inhalational Isoflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalational Isoflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalational Isoflurane in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalational Isoflurane Industry Trends Table 2. Inhalational Isoflurane Industry Drivers Table 3. Inhalational Isoflurane Industry Opportunities and Challenges Table 4. Inhalational Isoflurane Industry Restraints Table 5. Global Inhalational Isoflurane Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalational Isoflurane Revenue Share by Company (2021-2026) Table 7. Global Inhalational Isoflurane Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Inhalational Isoflurane Sales Volume Share by Company (2021-2026) Table 9. Global Inhalational Isoflurane Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Inhalational Isoflurane Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalational Isoflurane Key Company Manufacturing Base & Headquarters Table 12. Global Inhalational Isoflurane Company, Product Type & Application Table 13. Global Inhalational Isoflurane Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalational Isoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Brand Drug Table 18. Significant Companies of Generic Drugs Table 19. Global Inhalational Isoflurane Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhalational Isoflurane Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Inhalational Isoflurane Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Inhalational Isoflurane Sales Volume Share by Type (2021-2026) Table 23. Global Inhalational Isoflurane Sales Volume Share by Type (2027-2032) Table 24. Global Inhalational Isoflurane Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Inhalational Isoflurane Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Inhalational Isoflurane Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Inhalational Isoflurane Sales Value Share by Type (2021-2026) Table 28. Global Inhalational Isoflurane Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Other Table 32. Global Inhalational Isoflurane Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Inhalational Isoflurane Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Inhalational Isoflurane Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Inhalational Isoflurane Sales Volume Share by Application (2021-2026) Table 36. Global Inhalational Isoflurane Sales Volume Share by Application (2027-2032) Table 37. Global Inhalational Isoflurane Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Inhalational Isoflurane Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Inhalational Isoflurane Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Inhalational Isoflurane Sales Value Share by Application (2021-2026) Table 41. Global Inhalational Isoflurane Sales Value Share by Application (2027-2032) Table 42. Global Inhalational Isoflurane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Inhalational Isoflurane Sales by Region (2021-2026) & (K Units) Table 44. Global Inhalational Isoflurane Sales Market Share by Region (2021-2026) Table 45. Global Inhalational Isoflurane Sales by Region (2027-2032) & (K Units) Table 46. Global Inhalational Isoflurane Sales Market Share by Region (2027-2032) Table 47. Global Inhalational Isoflurane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Inhalational Isoflurane Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Inhalational Isoflurane Sales Value Share by Region (2021-2026) Table 50. Global Inhalational Isoflurane Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Inhalational Isoflurane Sales Value Share by Region (2027-2032) Table 52. Global Inhalational Isoflurane Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Inhalational Isoflurane Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Inhalational Isoflurane Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Inhalational Isoflurane Sales by Country (2021-2026) & (K Units) Table 57. Global Inhalational Isoflurane Sales Market Share by Country (2021-2026) Table 58. Global Inhalational Isoflurane Sales by Country (2027-2032) & (K Units) Table 59. Global Inhalational Isoflurane Sales Market Share by Country (2027-2032) Table 60. Global Inhalational Isoflurane Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Inhalational Isoflurane Sales Value Market Share by Country (2021-2026) Table 62. Global Inhalational Isoflurane Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Inhalational Isoflurane Sales Value Market Share by Country (2027-2032) Table 64. KALBE PHARMA Company Information Table 65. KALBE PHARMA Business Overview Table 66. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. KALBE PHARMA Inhalational Isoflurane Product Portfolio Table 68. KALBE PHARMA Recent Development Table 69. AbbVie Company Information Table 70. AbbVie Business Overview Table 71. AbbVie Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AbbVie Inhalational Isoflurane Product Portfolio Table 73. AbbVie Recent Development Table 74. LAB UNKNOWN Company Information Table 75. LAB UNKNOWN Business Overview Table 76. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. LAB UNKNOWN Inhalational Isoflurane Product Portfolio Table 78. LAB UNKNOWN Recent Development Table 79. Neon Laboratories Company Information Table 80. Neon Laboratories Business Overview Table 81. Neon Laboratories Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Neon Laboratories Inhalational Isoflurane Product Portfolio Table 83. Neon Laboratories Recent Development Table 84. Piramal Company Information Table 85. Piramal Business Overview Table 86. Piramal Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Piramal Inhalational Isoflurane Product Portfolio Table 88. Piramal Recent Development Table 89. PT Novell Pharmaceutical Company Information Table 90. PT Novell Pharmaceutical Business Overview Table 91. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio Table 93. PT Novell Pharmaceutical Recent Development Table 94. Sedana Medical Company Information Table 95. Sedana Medical Business Overview Table 96. Sedana Medical Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sedana Medical Inhalational Isoflurane Product Portfolio Table 98. Sedana Medical Recent Development Table 99. Baxter Company Information Table 100. Baxter Business Overview Table 101. Baxter Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Baxter Inhalational Isoflurane Product Portfolio Table 103. Baxter Recent Development Table 104. Viatris Company Information Table 105. Viatris Business Overview Table 106. Viatris Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Viatris Inhalational Isoflurane Product Portfolio Table 108. Viatris Recent Development Table 109. Lunan Beite Company Information Table 110. Lunan Beite Business Overview Table 111. Lunan Beite Inhalational Isoflurane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lunan Beite Inhalational Isoflurane Product Portfolio Table 113. Lunan Beite Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Inhalational Isoflurane Distributors List Table 117. Inhalational Isoflurane Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Inhalational Isoflurane Product Image Figure 2. Global Inhalational Isoflurane Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalational Isoflurane Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalational Isoflurane Sales (2021-2032) & (K Units) Figure 5. Global Inhalational Isoflurane Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Inhalational Isoflurane Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brand Drug Image Figure 10. Generic Drugs Image Figure 11. Global Inhalational Isoflurane Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhalational Isoflurane Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Inhalational Isoflurane Sales Volume Share by Type (2021-2032) Figure 14. Global Inhalational Isoflurane Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Inhalational Isoflurane Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Inhalational Isoflurane Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Other Image Figure 20. Global Inhalational Isoflurane Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Inhalational Isoflurane Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Inhalational Isoflurane Sales Volume Share by Application (2021-2032) Figure 23. Global Inhalational Isoflurane Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Inhalational Isoflurane Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Inhalational Isoflurane Sales Value Share by Application (2021-2032) Figure 26. Global Inhalational Isoflurane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Inhalational Isoflurane Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Inhalational Isoflurane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Inhalational Isoflurane Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Inhalational Isoflurane Sales Value (2021-2032) & (US$ Million) Figure 31. North America Inhalational Isoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Inhalational Isoflurane Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Inhalational Isoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Inhalational Isoflurane Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Inhalational Isoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Inhalational Isoflurane Sales Value (2021-2032) & (US$ Million) Figure 37. South America Inhalational Isoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Inhalational Isoflurane Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Inhalational Isoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Inhalational Isoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Inhalational Isoflurane Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Inhalational Isoflurane Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drugs
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • KALBE PHARMA
  • AbbVie
  • LAB UNKNOWN
  • Neon Laboratories
  • Piramal
  • PT Novell Pharmaceutical
  • Sedana Medical
  • Baxter
  • Viatris
  • Lunan Beite

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalational Isoflurane Sales Value (2021-2032)
  4. 1.2.2 Global Inhalational Isoflurane Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalational Isoflurane Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalational Isoflurane Market Dynamics
  1. 2.1 Inhalational Isoflurane Industry Trends
  2. 2.2 Inhalational Isoflurane Industry Drivers
  3. 2.3 Inhalational Isoflurane Industry Opportunities and Challenges
  4. 2.4 Inhalational Isoflurane Industry Restraints
3 Inhalational Isoflurane Market by Company
  1. 3.1 Global Inhalational Isoflurane Company Revenue Ranking in 2025
  2. 3.2 Global Inhalational Isoflurane Revenue by Company (2021-2026)
  3. 3.3 Global Inhalational Isoflurane Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalational Isoflurane Average Price by Company (2021-2026)
  5. 3.5 Global Inhalational Isoflurane Company Ranking (2024-2026)
  6. 3.6 Global Inhalational Isoflurane Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalational Isoflurane Company Product Type and Application
  8. 3.8 Global Inhalational Isoflurane Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalational Isoflurane Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalational Isoflurane Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalational Isoflurane Market by Type
  1. 4.1 Inhalational Isoflurane Type Introduction
  2. 4.1.1 Brand Drug
  3. 4.1.2 Generic Drugs
  4. 4.2 Global Inhalational Isoflurane Sales Volume by Type
  5. 4.2.1 Global Inhalational Isoflurane Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Inhalational Isoflurane Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Inhalational Isoflurane Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Inhalational Isoflurane Sales Value by Type
  9. 4.3.1 Global Inhalational Isoflurane Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Inhalational Isoflurane Sales Value by Type (2021-2032)
  11. 4.3.3 Global Inhalational Isoflurane Sales Value Share by Type (2021-2032)
5 Inhalational Isoflurane Market by Application
  1. 5.1 Inhalational Isoflurane Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Inhalational Isoflurane Sales Volume by Application
  6. 5.2.1 Global Inhalational Isoflurane Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalational Isoflurane Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Inhalational Isoflurane Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Inhalational Isoflurane Sales Value by Application
  10. 5.3.1 Global Inhalational Isoflurane Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalational Isoflurane Sales Value by Application (2021-2032)
  12. 5.3.3 Global Inhalational Isoflurane Sales Value Share by Application (2021-2032)
6 Inhalational Isoflurane Regional Sales and Value Analysis
  1. 6.1 Global Inhalational Isoflurane Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalational Isoflurane Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalational Isoflurane Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalational Isoflurane Sales by Region (2027-2032)
  5. 6.3 Global Inhalational Isoflurane Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalational Isoflurane Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalational Isoflurane Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalational Isoflurane Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalational Isoflurane Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalational Isoflurane Sales Value (2021-2032)
  12. 6.6.2 North America Inhalational Isoflurane Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalational Isoflurane Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalational Isoflurane Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalational Isoflurane Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalational Isoflurane Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalational Isoflurane Sales Value (2021-2032)
  21. 6.9.2 South America Inhalational Isoflurane Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalational Isoflurane Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalational Isoflurane Sales Value Share by Country, 2025 VS 2032
7 Inhalational Isoflurane Country-level Sales and Value Analysis
  1. 7.1 Global Inhalational Isoflurane Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalational Isoflurane Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalational Isoflurane Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalational Isoflurane Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalational Isoflurane Sales by Country (2027-2032)
  6. 7.4 Global Inhalational Isoflurane Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalational Isoflurane Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalational Isoflurane Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalational Isoflurane Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalational Isoflurane Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalational Isoflurane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KALBE PHARMA
  2. 8.1.1 KALBE PHARMA Company Information
  3. 8.1.2 KALBE PHARMA Business Overview
  4. 8.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 KALBE PHARMA Inhalational Isoflurane Product Portfolio
  6. 8.1.5 KALBE PHARMA Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Inhalational Isoflurane Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 LAB UNKNOWN
  14. 8.3.1 LAB UNKNOWN Company Information
  15. 8.3.2 LAB UNKNOWN Business Overview
  16. 8.3.3 LAB UNKNOWN Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 LAB UNKNOWN Inhalational Isoflurane Product Portfolio
  18. 8.3.5 LAB UNKNOWN Recent Developments
  19. 8.4 Neon Laboratories
  20. 8.4.1 Neon Laboratories Company Information
  21. 8.4.2 Neon Laboratories Business Overview
  22. 8.4.3 Neon Laboratories Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Neon Laboratories Inhalational Isoflurane Product Portfolio
  24. 8.4.5 Neon Laboratories Recent Developments
  25. 8.5 Piramal
  26. 8.5.1 Piramal Company Information
  27. 8.5.2 Piramal Business Overview
  28. 8.5.3 Piramal Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Inhalational Isoflurane Product Portfolio
  30. 8.5.5 Piramal Recent Developments
  31. 8.6 PT Novell Pharmaceutical
  32. 8.6.1 PT Novell Pharmaceutical Company Information
  33. 8.6.2 PT Novell Pharmaceutical Business Overview
  34. 8.6.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio
  36. 8.6.5 PT Novell Pharmaceutical Recent Developments
  37. 8.7 Sedana Medical
  38. 8.7.1 Sedana Medical Company Information
  39. 8.7.2 Sedana Medical Business Overview
  40. 8.7.3 Sedana Medical Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sedana Medical Inhalational Isoflurane Product Portfolio
  42. 8.7.5 Sedana Medical Recent Developments
  43. 8.8 Baxter
  44. 8.8.1 Baxter Company Information
  45. 8.8.2 Baxter Business Overview
  46. 8.8.3 Baxter Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Baxter Inhalational Isoflurane Product Portfolio
  48. 8.8.5 Baxter Recent Developments
  49. 8.9 Viatris
  50. 8.9.1 Viatris Company Information
  51. 8.9.2 Viatris Business Overview
  52. 8.9.3 Viatris Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Viatris Inhalational Isoflurane Product Portfolio
  54. 8.9.5 Viatris Recent Developments
  55. 8.10 Lunan Beite
  56. 8.10.1 Lunan Beite Company Information
  57. 8.10.2 Lunan Beite Business Overview
  58. 8.10.3 Lunan Beite Inhalational Isoflurane Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lunan Beite Inhalational Isoflurane Product Portfolio
  60. 8.10.5 Lunan Beite Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalational Isoflurane Value Chain Analysis
  2. 9.1.1 Inhalational Isoflurane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalational Isoflurane Sales Mode & Process
  6. 9.2 Inhalational Isoflurane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalational Isoflurane Distributors
  9. 9.2.3 Inhalational Isoflurane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst